Assignee

ADAMAS PHARMACEUTICALS INC

US·20 granted patents·41 pending applications·382 citations·filing 2005–2021

Technology mixA61P61 A61K59 Y02A11 C07C2

Top patents by PatentIndex Score

61 records

0199US9072697B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Granted Jul 7, 2015·22 cites·16 claims
0298US8987333B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Mar 24, 2015·20 cites·11 claims
0398US8895617B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·17 claims
0498US8895618B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·12 claims
0598US8895616B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·14 claims
0698US8895615B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·16 claims
0798US8895614B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·11 claims
0898US8889740B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 18, 2014·21 cites·9 claims
0998US8796337B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·27 cites·14 claims
1098US7619007B2Method and composition for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Nov 17, 2009·53 cites·20 claims
1197US8580858B2Compositions for the treatment of CNS-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Nov 12, 2013·22 cites·10 claims
1297US8362085B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Jan 29, 2013·33 cites·12 claims
1396US8598233B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Dec 3, 2013·21 cites·18 claims
1492US7981930B2Compositions and kits for treating influenzaADAMAS PHARMACEUTICALS INC·Filed 2008·Granted Jul 19, 2011·22 cites·7 claims
1592US7858660B2Compositions and kits for treating influenzaADAMAS PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·20 cites·44 claims
1688US10987324B2Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2018·Granted Apr 27, 2021·3 cites·18 claims
1786US7326730B2Aminoadamantane derivatives as therapeutic agentsADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Feb 5, 2008·7 cites·13 claims
1880US10973783B2Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2016·Granted Apr 13, 2021·1 cites·34 claims
1975US11890261B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2021·Granted Feb 6, 2024·0 cites·18 claims
2074US2014135529A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
2173US2017151189A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
2273US2017151188A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
2372US2013165517A1Composition and Method for Treating Neurological DiseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
2470US2015045446A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
2570US2015051292A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
2670US2015045438A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
2770US2015045439A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
2870US2015045448A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
2970US2015045447A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
3070US2015057355A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
3169US2014336266A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
3269US2016263052A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
3369US2016263058A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
3469US2014242163A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
3569US2016256413A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
3667US2014134243A1Compositions for the Treatment of CNS-Related ConditionsADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
3767US2014179797A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
3866US2016243093A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
3966US2016250149A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4066US2016243094A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4166US2016243035A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4266US2016220545A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4366US2016243058A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4466US2016250161A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4566US2022062204A1Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
4666US2016243095A1Compositions for the treatment of cns-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
4764US11833121B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2020·Granted Dec 5, 2023·0 cites·16 claims
4864US2016263053A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
4964US2016256414A1Amantadine compositions and methods of useADAMAS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
5064US2017056340A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites

Showing the top 50 of 61 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when ADAMAS PHARMACEUTICALS INC files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →